Shopping Cart

No products in the cart.

BS EN ISO 10993-18:2020

$215.11

Biological evaluation of medical devices – Chemical characterization of medical device materials within a risk management process

Published By Publication Date Number of Pages
BSI 2020 84
Guaranteed Safe Checkout
Categories: ,

If you have any questions, feel free to reach out to our online customer service team by clicking on the bottom right corner. We’re here to assist you 24/7.
Email:[email protected]

This document specifies a framework for the identification, and if necessary, quantification of constituents of a medical device, allowing the identification of biological hazards and the estimation and control of biological risks from material constituents, using a generally stepwise approach to the chemical characterization which can include one or more of the following:

  • the identification of its materials of construction (medical device configuration);

  • the characterization of the materials of construction via the identification and quantification of their chemical constituents (material composition);

  • the characterization of the medical device for chemical substances that were introduced during manufacturing (e.g. mould release agents, process contaminants, sterilization residues);

  • the estimation (using laboratory extraction conditions) of the potential of the medical device, or its materials of construction, to release chemical substances under clinical use conditions (extractables);

  • the measurement of chemical substances released from a medical device under its clinical conditions of use (leachables).

This document can also be used for chemical characterization (e.g. the identification and/or quantification) of degradation products. Information on other aspects of degradation assessment are covered in ISO 10993-9, ISO 10993-13, ISO 10993-14 and ISO 10993-15.

The ISO 10993 series is applicable when the material or medical device has direct or indirect body contact (see ISO 10993-1 for categorization by nature of body contact).

This document is intended for suppliers of materials and manufacturers of medical devices, to support a biological evaluation.

PDF Catalog

PDF Pages PDF Title
2 undefined
6 Annex ZA (informative)Relationship between this European standard and the General Safety and Performance Requirements of Regulation (EU) 2017/745 aimed to be covered
8 Annex ZB (informative)Relationship between this European Standard and the essential requirements of Directive 90/385/EEC [OJ L 189] aimed to be covered
10 Annex ZC (informative)Relationship between this European standard and the General Safety and Performance Requirements of Regulation (EU) 2017/745 aimed to be covered
13 Foreword
14 Introduction
16 1 Scope
2 Normative references
17 3 Terms and definitions
21 4 Symbols and abbreviated terms
22 5 Characterization procedure
5.1 General
25 5.2 Establish medical device configuration and material composition
5.2.1 General
26 5.2.2 Information gathering
5.2.3 Information generation
27 5.3 Assess material/chemical equivalence to a clinically established material or medical device
28 5.4 Assess the hypothetical worst-case chemical release based on total exposure to the medical device’s chemical constituents
5.4.1 Establish the hypothetical worst-case chemical release
5.4.2 Assess the hypothetical worst-case chemical release
29 5.5 Establish an analytical evaluation threshold
5.6 Estimate the chemical release; perform extraction study
32 5.7 Assess the estimated chemical release (extractables profile)
5.8 Determine the actual chemical release; perform leachables study
34 5.9 Assess the actual chemical release (leachables profile)
5.10 Exiting the chemical characterization process
6 Chemical characterization parameters and methods
6.1 General
35 6.2 Material composition
37 6.3 Extractables and leachables
39 6.4 Structural composition or configuration
40 6.5 Analytical methods
41 7 Reporting of the chemical characterization data
42 Annex A (informative) General principles of chemical characterization
46 Annex B (informative) Information sources for chemical characterization
50 Annex C (informative) Principles for establishing biological equivalence
53 Annex D (informative) Principles of sample extraction
65 Annex E (informative) Calculation and application of the analytical evaluation threshold (AET)
73 Annex F (informative) Qualification of analytical methods used for extractables/leachables
76 Annex G (informative) Reporting details for analytical methods and chemical data
79 Bibliography
BS EN ISO 10993-18:2020
$215.11